BIDMC’s Research & Health News Digest – COVID-19 Special Edition

Beth Israel Deaconess Medical Center

Newswise — Welcome to the COVID-19 Special Edition of Beth Israel Deaconess Medical Center’s (BIDMC) Research & Health News Digest.

This edition’s update includes:

  • Collaboration to Open Up New Supply Chain to Alleviate Shortage of Medical Supplies Caused by COVID-19
  • Hydroxychloroquine for Treatment of COVID-19 Linked to Increased Risk of Cardiac Arrhythmias
  • Researchers Reveal Substantial Disparities in COVID-19 Hospitalization and Death Rates Among New York City Boroughs
  • BIDMC Immunologist at the Forefront of the Race for a COVID-19 Vaccine
  • Inside the Race to Launch BIDMC’s In-House COVID-19 Testing Capabilities
  • BIDMC-Led Clinical Trial Identifies Four Novel 3D-Printed Swabs for Use in COVID-19 Testing
  • BIDMC Enrolling Patients in Clinical Trials Evaluating Existing Drug as Treatment for Severe COVID-19
  • BIDMC Launches Clinical Trial to Assess Common Anti-Clotting Medication for Treatment of COVID-19-Related Respiratory Failure
  • When is it Okay to Go to Urgent Care?
  • Stay Connected to Your Doctors with Telemedicine
  • COVID-19 and Pregnancy
  • Combatting COVID-19 Stress: Advice from BIDMC Mental Health Experts
  • New Ambulatory COVID-19 Testing Sites Open at Beth Israel Deaconess HealthCare – Chelsea and Bowdoin Street Health Center

If any of these briefs pique your interest and you’d like to speak with one of our experts, please contact us at mediarelations@bidmc.harvard.edu. You can also reach the BIDMC communications team member on call through the BIDMC page operator at (617) 667-4700 by asking for pager ID #33880.

 

Collaboration to Open Up New Supply Chain Alleviates Shortage of Medical Supplies Caused by COVID-19
Mark L. Zeidel, MD, Chair of the Department of Medicine at Beth Israel Deaconess Medical Center, describes how a state taskforce mobilized to produce testing supplies, medical devices and personal protective equipment for health care workers fighting the epidemic. https://www.bidmc.org/about-bidmc/news/2020/05/supply-chain

Hydroxychloroquine for Treatment of COVID-19 Linked to Increased Risk of Cardiac Arrhythmias
A team of pharmacists and clinicians at Beth Israel Deaconess Medical Center has found evidence suggesting that patients who received hydroxychloroquine for COVID-19 were at increased risk of electrical changes to the heart and cardiac arrhythmias.
https://www.bidmc.org/about-bidmc/news/2020/05/hydroxychloroquine-for-treatment-of-covid-19-linked-to-increased-risk-of-cardiac-arrhythmias

Researchers Reveal Substantial Disparities in COVID-19 Hospitalization and Death Rates Among New York City Boroughs
A study led by researchers at Beth Israel Deaconess Medical Center and published in the Journal of the American Medical Association (JAMA), suggests that substantial differences in COVID-19-related hospitalizations and deaths have emerged along racial and socioeconomic lines in New York City.
https://www.bidmc.org/about-bidmc/news/2020/04/nyc-covid-19-rates

BIDMC Immunologist at the Forefront of the Race for a COVID-19 Vaccine
Immunologist Dan Barouch, MD, PhD has become a world leader in the race to develop a vaccine against SARS-CoV-2, the virus that causes COVID-19. As Director of BIDMC’s Center for Virology and Vaccine Research, Barouch and his colleagues began working on a COVID-19 vaccine on January 10, the night Chinese scientists released the SARS-CoV-2 virus’s genome.
https://www.bidmc.org/about-bidmc/news/2020/04/barouch

Inside the Race to Launch BIDMC’s In-House COVID-19 Testing Capabilities
A team at Beth Israel Deaconess Medical Center implemented an in-house COVID-19 test soon after the US Food and Drug Administration (FDA) granted American healthcare institutions permission to do so. In the process, the team launched the first high throughput COVID-19 test in a New England medical center.
https://www.bidmc.org/about-bidmc/news/2020/04/inside-the-race-to-launch-bidmcs-in-house-covid-19-testing-capabilities

BIDMC-Led Clinical Trial Identifies Four Novel 3D-Printed Swabs for Use in COVID-19 Testing
In an effort coordinated by Ramy Arnaout, MD, DPhil, Associate Director of the Clinical Microbiology Laboratories at Beth Israel Deaconess Medical Center, four novel prototypes of 3D-printed swabs that can be used for COVID-19 testing have been identified.
https://www.bidmc.org/about-bidmc/news/2020/04/3d-printed-swabs

BIDMC Enrolling Patients in Clinical Trials Evaluating Existing Drug as Treatment for Severe COVID-19
Pulmonary Specialist Robert Hallowell, MD, Medical Director of Beth Israel Deaconess Medical Center’s Pulmonary Clinic, will lead Phase 2/3 multi-site trials to evaluate a potential treatment for patients with COVID-19.
https://www.bidmc.org/about-bidmc/news/2020/04/covid-19-clinical-trial

BIDMC Launches Clinical Trial to Assess Common Anti-Clotting Medication for Treatment of COVID-19-Related Respiratory Failure
A team of physician-scientists at Beth Israel Deaconess Medical Center have begun to enroll patients in a clinical trial to evaluate a common anti-clotting drug for the treatment of COVID-19-positive patients with acute respiratory distress syndrome.
https://www.bidmc.org/about-bidmc/news/2020/04/covid-19-anti-clotting-medication

When is it Okay to Go to Urgent Care?
Barbara A. Masser, MD, Medical Director at Beth Israel Deaconess Medical Center urgent care centers in Chelsea and Chestnut Hill, offers advice to help you make the right decision when your care cannot wait.
https://www.bidmc.org/about-bidmc/wellness-insights/covid-19-health-and-wellness/2020/04/when-is-it-okay-to-go-to-urgent-care

Stay Connected to Your Doctors with Telemedicine
Eli Gelfand, MD, Section Chief of General Cardiology at Beth Israel Deaconess Medical Center, shares advice about the use of telemedicine to consult with your healthcare providers during the COVID-19 crisis.
https://www.bidmc.org/about-bidmc/wellness-insights/covid-19-health-and-wellness/2020/04/telemedicine

COVID-19 and Pregnancy
Beth Israel Deaconess Medical Center’s Blair Wylie, MD, MPH, Director of Maternal-Fetal Medicine, and Chloe Zera, MD, MPH, Director of Obstetric Population Health, provide information and advice for expecting parents during the COVID-19 pandemic.
https://www.bidmc.org/about-bidmc/wellness-insights/covid-19-health-and-wellness/2020/03/covid-19-and-pregnancy

Combatting COVID-19 Stress: Advice from BIDMC Mental Health Experts
Beth Israel Deaconess Medical Center’s Digital Psychiatry Director, John Torous, MD, and Psychologist Pamela Peck, PsyD, joins other experts to offer advice for keeping stress in check and maintaining your emotional wellbeing.
https://www.bidmc.org/about-bidmc/wellness-insights/covid-19-health-and-wellness/2020/03/combatting-covid-19-stress-advice-from-bidmc-mental-health-experts

New Ambulatory COVID-19 Testing Sites Open at Beth Israel Deaconess HealthCare – Chelsea and Bowdoin Street Health Center.
Beth Israel Deaconess Medical Center has expanded its ambulatory COVID-19 testing locations with the addition of  sites at Beth Israel Deaconess HealthCare-Chelsea and Bowdoin Street Health Center.
https://www.bidmc.org/about-bidmc/news/2020/04/chelsea-covid-19-testing
https://www.bidmc.org/about-bidmc/news/2020/04/bowdoin-covid-19-testing




Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
VIDEO
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.


Showing results

110 of 2816

close
1.47097